Long-term effect of stereotactic body radiation therapy for primary hepatocellular carcinoma ineligible for local ablation therapy or surgical resection. Stereotactic radiotherapy for liver cancer.
about
Therapeutic Strategies in HCC: Radiation ModalitiesHow to Improve Therapeutic Ratio in Radiotherapy of HCCLiver-Directed Radiotherapy for Hepatocellular CarcinomaRole of stereotactic body radiation therapy for hepatocellular carcinomaHepatocellular Carcinoma: The Role of Interventional OncologyTechnical advances in external radiotherapy for hepatocellular carcinomaRadiation therapy has been shown to be adaptable for various stages of hepatocellular carcinomaRole of local ablative therapy for hepatocellular carcinomaSignificance of an increase in the Child-Pugh score after radiotherapy in patients with unresectable hepatocellular carcinomaTumor response assessment by MRI following stereotactic body radiation therapy for hepatocellular carcinoma.Local effect of stereotactic body radiotherapy for primary and metastatic liver tumors in 130 Japanese patients.Strategies to tackle the challenges of external beam radiotherapy for liver tumorsBone marrow-derived stromal cell therapy in cirrhosis: clinical evidence, cellular mechanisms, and implications for the treatment of hepatocellular carcinoma.Radiation therapy for liver tumors: ready for inclusion in guidelines?Effects of drinking hydrogen-rich water on the quality of life of patients treated with radiotherapy for liver tumorsRobotic stereotactic body radiation therapy for liver-limited malignant tumorsRole of radiotherapy in the management of hepatocellular carcinoma: A systematic review.Minimally invasive local therapies for liver cancerStereotactic body radiation therapy for hepatocellular carcinoma: prognostic factors of local control, overall survival, and toxicityStereotactic body radiation therapy as an alternative treatment for small hepatocellular carcinoma.Costunolide causes mitotic arrest and enhances radiosensitivity in human hepatocellular carcinoma cellsLocally ablative therapies for primary and metastatic liver cancer.Early experience of helical tomotherapy for hepatobiliary radiotherapyOutcomes After Stereotactic Body Radiotherapy or Radiofrequency Ablation for Hepatocellular Carcinoma.A Survey of Stereotactic Body Radiotherapy in KoreaAlpha-fetoprotein normalization as a prognostic surrogate in small hepatocellular carcinoma after stereotactic body radiotherapy: a propensity score matching analysis.Long-term survival analysis in combined transarterial embolization and stereotactic body radiation therapy versus stereotactic body radiation monotherapy for unresectable hepatocellular carcinoma >5 cm.Gated Volumetric-Modulated Arc Therapy vs. Tumor-Tracking CyberKnife Radiotherapy as Stereotactic Body Radiotherapy for Hepatocellular Carcinoma: A Dosimetric Comparison Study Focused on the Impact of Respiratory Motion Managements.External beam radiotherapy for unresectable hepatocellular carcinoma, an international multicenter phase I trial, SAKK 77/07 and SASL 26Cyberknife treatment for advanced or terminal stage hepatocellular carcinomaComparison of percutaneous radiofrequency ablation and CyberKnife(®) for initial solitary hepatocellular carcinoma: A pilot study.Feasibility and efficacy of stereotactic ablative radiotherapy for Barcelona Clinic Liver Cancer-C stage hepatocellular carcinomaMulti-institutional comparison of treatment planning using stereotactic ablative body radiotherapy for hepatocellular carcinoma - benchmark for a prospective multi-institutional study.Multi-Institutional Phase II Study of High-Dose Hypofractionated Proton Beam Therapy in Patients With Localized, Unresectable Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma.Practical patterns for stereotactic body radiotherapy to hepatocellular carcinoma in Korea: a survey of the Korean Stereotactic Radiosurgery Group.National Cancer Centre Singapore Consensus Guidelines for Hepatocellular Carcinoma.Application of Radiotherapeutic Strategies in the BCLC-Defined Stages of Hepatocellular CarcinomaHigh-dose hypofractionated X-ray radiotherapy for hepatocellular carcinoma: Tumor responses and toxicitiesRadiation-induced liver disease after stereotactic body radiotherapy for small hepatocellular carcinoma: clinical and dose-volumetric parametersEastern Canadian Gastrointestinal Cancer Consensus Conference 2016.
P2860
Q26738658-6E7A7561-86A6-4ABC-9D61-8639A8DF8C93Q26738862-F5C2553D-0396-4040-B95D-1BDC93DFB69EQ26738869-E3337330-6400-4952-AA90-CBCFDB5C5A76Q26864969-3FA14D74-6BC8-481F-99D7-21E4BC8DC22EQ28071444-3941C119-EDB6-42CF-A4A0-664348153538Q28079760-AFB21D18-9CAE-4228-85DC-F564C4EC11D7Q28084869-2E4A5D28-132C-4BB5-A488-0E5374932AB7Q30417048-00B6D2BB-E261-4AD0-9755-5928463854C3Q33593108-D063563D-B278-41EC-AC72-B6417D9BAF64Q33602716-7E5B0E9B-EBE3-4963-8011-45B278E4115BQ33645887-EBB85D93-5A7E-4A74-ACDF-4F4EED3F6037Q33706721-A1E3437E-E9F9-4F7C-99AF-86794A2E0EB1Q33818431-6D271EFA-ED86-417C-81ED-D82022038453Q34005194-EB50ADC3-CFF2-4CF2-9FE1-C4CAD8D84E25Q34238732-46D069A5-04F1-4B51-965F-3DEBB222FEF3Q34791775-A0BD3A00-F3B1-4BB2-BEA4-B6F3B6AFD183Q34966816-701E9FDE-51A7-4BCB-885A-8D136DC6E0E9Q34974386-F9DA2AC6-ED84-4827-B45C-9CFBF155C681Q35023155-FE064616-9AC6-4E4C-936C-669E904F7913Q35047457-569192BD-91A4-419E-8F75-9BE07B502B39Q35069284-7BAB760E-EDA9-4E45-B0FD-021A8B565586Q35152457-A35B5E82-A453-458C-A20A-1EEA1411E4A7Q35545055-A7E3644C-FD7B-42F2-8A05-69B07061EB1FQ35858275-1E5EE671-26EE-4F35-B739-D169B61016CFQ35862313-A6E5499E-637F-4383-8748-126472C47DF0Q35872656-AA5017F3-B23B-4E65-A856-EA0043583C02Q36181619-2CD06712-83E0-4B5C-B813-DA9900861533Q36201159-A82CC883-E55F-4F84-B696-DF06048E5198Q36249520-657B464B-BA88-4352-B08B-631489A050AEQ36360832-B569F87A-7F0A-490B-86B6-3670E06039EAQ36401584-2BA90F84-BC2F-44EA-95C3-753D264B614EQ36589471-BD2C901D-01E6-4D58-8B8C-33F5B5EBDE8DQ36843349-BB6F3A50-C0AF-4429-B1F7-27A8226344F5Q36914411-90780E32-37BD-406E-9F75-7F20514BE014Q36949330-5C59B04F-82BA-4A94-B4BC-527D4CE942CDQ37000692-ED6C325B-FB04-463B-A11F-CA646D5C56F4Q37140658-28EA4E87-8BB0-459A-A098-5B5BEB0240B9Q37269624-9B179C17-786A-4D40-B304-EB20667B7708Q37277060-CF748132-0B5C-49D0-AB03-957AF017A8F6Q37524976-D187CBAB-4CAE-40C2-B71B-D295BB712CD2
P2860
Long-term effect of stereotactic body radiation therapy for primary hepatocellular carcinoma ineligible for local ablation therapy or surgical resection. Stereotactic radiotherapy for liver cancer.
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Long-term effect of stereotact ...... radiotherapy for liver cancer.
@ast
Long-term effect of stereotact ...... radiotherapy for liver cancer.
@en
type
label
Long-term effect of stereotact ...... radiotherapy for liver cancer.
@ast
Long-term effect of stereotact ...... radiotherapy for liver cancer.
@en
prefLabel
Long-term effect of stereotact ...... radiotherapy for liver cancer.
@ast
Long-term effect of stereotact ...... radiotherapy for liver cancer.
@en
P2093
P2860
P356
P1433
P1476
Long-term effect of stereotact ...... radiotherapy for liver cancer.
@en
P2093
Byung Ock Choi
Hong Seok Jang
Jeong Won Jang
Ji Yoon Kim
Jong Young Choi
Jung Hyun Kwon
Kyu Won Chung
Seung Kew Yoon
Si Hyun Bae
P2860
P2888
P356
10.1186/1471-2407-10-475
P407
P577
2010-09-03T00:00:00Z
P5875
P6179
1002039887